These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2440196)

  • 1. Glutaraldehyde inactivated pertussis vaccine: a safe vaccine in the innocuity test.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1987 Jun; 5(2):102-4. PubMed ID: 2440196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Indian J Med Res; 1992 Jan; 95():8-11. PubMed ID: 1577522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Apr; 15(2):159-64. PubMed ID: 3110164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of elevated temperatures on the opacity and toxicity of pertussis vaccines manufactured with different inactivating agents.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1986 Sep; 4(3):185-90. PubMed ID: 3094265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1988 Dec; 6(6):491-6. PubMed ID: 2907704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine.
    Scheifele DW; Bjornson G; Halperin SH; Mitchell L; Boraston S
    CMAJ; 1994 Jan; 150(1):29-35. PubMed ID: 8275406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis vaccine: reactivity in animal and man.
    Mebel S; Rustenbach S; Giese H; Winkler C; Thilo W
    Dev Biol Stand; 1977; 34():207-11. PubMed ID: 838145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on pertussis vaccine batches inactivated with glutaraldehyde, beta-propiolactone, formaldehyde or thiomersal.
    Andreescu V; Caffé I; Marion M; Ivan I; David C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):299-308. PubMed ID: 122592
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement in the laboratory methods of assessing the safety of the of the pertussis component of DPT vaccine adsorbed].
    Chuprinina RP; Il'nitskaia EA; Polikar A; Vŭlchev V; Mikhaĭlova V; Niedermayer N; Pruchová J; Kardymowics B; Kudelski Z; Rymkewics D
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Jan; (1):28-33. PubMed ID: 1414103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.
    Saran G
    J Biol Stand; 1985 Oct; 13(4):315-20. PubMed ID: 4055808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactogenicity of fluid compared with adsorbed diphtheria-pertussis-tetanus vaccine.
    Mathias RG
    Can Med Assoc J; 1984 Jun; 130(12):1561-5. PubMed ID: 6610469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between mouse intracerebral potency & 50 per cent histamine sensitizing dose of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Indian J Med Res; 1989 May; 89():144-9. PubMed ID: 2476391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local reactions of Zwittergent-containing meningococcal vaccine after intramuscular injection in rats: comparison with the effect of diphtheria-pertussis-tetanus-polio vaccine.
    Speijers GJ; Danse LH; Beuvery EC; Derks HJ; Vos JG
    Vaccine; 1988 Oct; 6(5):419-22. PubMed ID: 3143190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of glutaraldehyde for the preparation of pertussis vaccine.
    Gupta RK
    Vaccine; 1990 Aug; 8(4):409-10. PubMed ID: 2118706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.